Skip to main content
. 2020 Jul 17;32(6):2845–2853. doi: 10.1016/j.jksus.2020.07.007

Fig. 1.

Fig. 1

The binding poses and LigPlot + results showing molecular interaction between SARS-CoV-2 3CLpro and lead molecules-(FDA approved antiviral drugs) (A) DB13879 (Glecaprevir) (B) DB09102 (Daclatasvir) (C) DB09297 (Paritaprevir). The hydrophobic interacting residues are indicated by red arcs with spikes and the green dashed lines with the bond distance correspond to hydrogen bonds.